Meet the Apollos Diagnostics Team

  • Jim Sargent

    Managing Partner

    Jim is the Managing Partner and founder of RQR PARTNERS®. Jim’s focus is our corporate development in international markets. With over 25 years of experience in executive and general management roles within life sciences, including his expatriate assignments, he brings a truly global lens when it comes to evaluating potential investments. His active participation as a facilitator in our global COMMERCIAL VIABILITY ACADEMY® programs makes him uniquely qualified to identify potential portfolio investments for both commercial viability and precommercial exit.

  • John P Alderete, PhD, MBA

    Founder

    John has applied his life sciences training, experience, and expertise in infectious diseases to a wide range of medical device technology companies. As the co-founder, Vice President, and Chief Scientific Officer of Xenotope Diagnostics, Inc. he led the project team responsible for developing the OSOM™ rapid Trichomonas test currently being sold Sekisui Diagnostics, Japan (formerly Genzyme Diagnostics, Cambridge, MA). John was responsible for coordinating product development, commercialization, clinical, quality and regulatory activities, including the management of the FDA approval process for two successful 510(K) submissions. Prior to founding Xenotope, John has worked as a Consultant at Plan A, a biotechnology consulting firm. In this role he supported product monitoring, market opportunity assessments, and licensing analyses for a variety of products and multi-national clients. As a consultant for Larvol Consulting Group, John assisted a multi-billion dollar oncology distribution company with sourcing, screening and helping to implement the outsourcing of sales efforts. As the former Associate Director for Corporate Relations for the Stanford University School of Medicine, John helped build the current and successful corporate engagement landscape for the School of Medicine.

    John received his Bachelor of Arts in biology from Reed College, his PhD in microbiology from the University of Washington in conjunction with the Fred Hutchinson Cancer Research Center, and his MBA with distinction from the University of Texas.

  • Kathleen A Kennedy, PhD

    Chief Scientific Officer

    Kathleen has over 25 years’ experience conducting research in academic and non-profit research settings. Her recent work has focused on infectious disease and the innate immune response. She has a strong grounding in molecular biology and immunology, and pioneered the application of cutting-edge systems-scale technologies to biological investigations. As Chief Scientific Officer, Kathleen is responsible for managing the company’s scientific, technological, and research operations while setting relevant priorities within the organization and aligning priorities with those of the overall mission.

    As a senior scientist at the Institute for Systems Biology, Kathleen managed the specific aims and scientific progress of the genomics sections of multimillion dollar grants and contracts. She established, grew, and managed a genomics core while being responsible for projects associated with consortia investigations involving research groups and institutions around the globe. These efforts produced data leading to over 20 publications and multiple competitive funding renewals. In addition to working with infectious microorganisms, Kathleen has expertise working with antibodies in specialized techniques for biological research; from conventional immunoassays to nonstandard chromatin immunoprecipitation methods for genomewide location analysis.

    Kathleen earned a BSc in Biology from the University of British Columbia, a PhD in Microbiology from the University of Washington, and received training at various institutions including The Institute for Systems Biology, and the Center for Infectious Disease Research (formerly Seattle BioMed), University of California San Francisco, and McGill University.

  • Robin Hellen, MS

    Head of Regulatory Affairs

    Robin has over 20 years of experience in regulatory and clinical services to the in-vitro medical device community, with an emphasis on regulatory submissions, clinical research management, new product development, systems validation, and technical writing. Throughout her career, she has served as a multi-specialty provider of FDA oriented regulatory services to both large and small medical device companies. Previously, Robin worked exclusively on site for clients including the U.S. Navy (NHRA), the UC/VA Medical Centers and large pharma/bio research corporations as Director of Regulatory Affairs, and Sr. Regulatory Affairs Research Specialist.

    Currently, Robin specializes in device-centered strategic planning and FDA submissions to include Premarket Approval Applications (PMA), Premarket Notifications (510[k]), Emergency Use Authorizations (EUA) and Breakthrough Device Designations (BDDR) submissions. Supplemental areas of expertise include ISO 13485/QMS, Good Manufacturing Practices, CLIA and QA/QC audits. Robin has provided detailed services to medical device manufacturers, clinical research sites, medical laboratories, and product development consultants. A long standing passion for excellence in the development and implementation of IVD tests has led to a positive relationship with the FDA and strong rate of regulatory approval.

    As Head of Regulatory Affairs, Robin oversees the company’s industry-specific practices and ensures all government and company regulations are in compliance. She directs the regulation process and clinical trials requiring governmental approval by ensuring that all necessary applications are filed and handling all government interactions.

    Robin earned her BS in Biology at University of San Diego, an MS in Forensic Science and holds various Regulatory Affairs and Medical Writing certifications.

  • James Joslin

    Chief Legal Officer

    As General Counsel for RQR, Jim brings more than 20 years of experience managing complex commercial transactions and disputes. Jim’s experience includes executive-level positions at Honeywell International Inc., where he was general counsel of Honeywell Resins & Chemicals and Chief Litigation Counsel of Honeywell Automation & Control Solutions. Before joining Honeywell, Jim was a partner at Kirkland & Ellis LLP in Chicago, where he practiced for thirteen years. At Kirkland, Jim served as lead trial counsel in commercial, financial, restructuring and technology related disputes. Jim also advised many of Kirkland’s private equity clients on a wide range of matters. Jim began his legal career as law clerk for the Honorable Karen Nelson Moore on the United States Court of Appeals for the Sixth Circuit.

  • Adam Wang

    Chief Chinese Commercial Advisor

    Adam Wang, MD, is our Commercial Advisor for greater China. With over 20 years of executive experience leading medical device companies, including designing and implementing commercial strategies for new medical devices in China, he allows us to recognize an innovation’s full global potential. He was the first employee of St. Jude Medical China, founding and managing the company's Cardiac Rhythm Management (CRM) division. He later led the CRM team for Boston Scientific China, reorganizing the commercial structure while redesigning the market strategy. Most recently he served as General Manager of Optomed China, founding and managing Optomed's wholly owned Chinese subsidiary. In this role he was responsible for leading and introducing the company's novel non-mydriatic hand-held fundus camera technology to the country, expanding the market from ophthalmology into diabetic management.

    Mr. Wang began his career in clinical practice as a surgeon at Shanghai Huadong Hospital after graduating from Shanghai Medical College of Fudan University. He also holds an EMBA from China Europe International Business School and a Certificate in Strategic Marketing from the University of Michigan.

  • Tony Hessburg

    Operations & Marketing

    Tony brings proven, forward-thinking commercialization, business strategy, digital transformation, marketing, branding and technology implementation. He has deep experience working with European companies on developing commercial pathways and managing US marketing and channel efforts, and he established and operates the Commercial Viability Academy.

    Founder of a marketing and technology services provider, Tony brings comprehensive experience working with startups to leading global brands including Allaction Sports Group, Blattner Energy, Aveda, Crestliner, Clarins, Coloplast, Deluxe, Eyemart Express, HOYA, Laura Mercier, LensCrafters, M Health C.O.R.E., Nyakio, Ottobock, Palmer Snowboards, Pearle Vision, Polaris, Power Plate, Ranger Boats, Ray Ban, Red Bull, Trek, Victory Motorcycles, Unicef and Vision-Ease.

  • Brian Wallenfelt

    Chief Intellectual Property Counsel

    Brian is a registered patent attorney at Wallenfelt Law PLC. His practice focuses on strategic patent counseling, prosecution, and licensing in medical device and computer/software technologies. Brian helps clients with, for example, patent application preparation and filing, prosecution (i.e., communicating with the USPTO during the patent examination process), patentability and freedom-to-operate searches, infringement and validity analysis, and licensing.

    Brian has represented clients of all sizes. A few of his more well-known clients include Cochlear Corporation, WelchAllyn/Hill-Rom, Beckman Coulter, Brown University, Spotify, Google, Microsoft, Adobe, and Twitter. Prior to forming his own firm, Brian worked at the national IP boutique firms for 7+ years. Prior to his legal career, Brian served in various engineering and management roles at multiple technology and medical device companies—ranging in maturity from early-stage startup to established multinational. He is a prolific inventor with over twenty patent applications filed, many of which have now issued as patents.